Published September 5, 2012
She was selected for the competitive $40,000 grant to investigate a pharmacological approach to treat hereditary neuropathy of the Charcot-Marie-Tooth (CMT) disease type.
They will perform a preclinical trial of a known drug for
arthritis in an authentic transgenic mouse model of CMT, using
behavioral, behavioral, electrophysiological, histological and
biochemical methods to measure effects on myelination.